Rahul Datta, MD, PhD

About Rahul Datta, MD, PhD

Titles

Attending Physician

Certifications

General Pediatrics - American Board of Pediatrics

Allergy and Immunology – American Board of Allergy and Immunology

Awards and Honors

2016, AAAAI Fellows in Training Travel Grant for Participation in the 2016 Annual Meeting

2009, F30 Grant – National Heart, Lung, and Blood Institute. Regulation of IL4 Signal Transduction by Poly(ADP-ribose) polymerase-1

2006, The McLaughlin Award from the Institute for Human Infections and Immunity - Best Oral Presentation on Immunology or Infectious Diseases

Education & training

Undergraduate Degree

University of North Carolina, Chapel Hill, NC

Graduate Degree

PhD - LSU Health Sciences Center, New Orleans, LA

Medical Degree

MD - LSU Health Sciences Center, New Orleans, LA

Residency

General Pediatrics - University of Texas Southwestern, Dallas, TX

Fellowship

Allergy and Immunology - Yale School of Medicine, New Haven, CT

Team affiliations

 View fewer team affiliations View all team affiliations

Publications

Publications

2022

Gabryszewski, S., Datta, R. Chapter 22: Allergic Rhinitis. Netter’s Pediatrics 2nd Edition, June 2022.

Datta, R., Jones, S. Cracking the Nut: Oral Immunotherapy Conundrums. Journal of Allergy and Clinical Immunology In Practice, 2022 June 1.

2014

Datta, R., Kuruvilla, M., Gill M., de la Morena M. Association of skin necrosis with subcutaneous immunoglobulin therapy. Annals of Allergy, Asthma & Immunology, 2014 July 31.

2011

Datta R, Naura AS, Zerfaoui M, Errami Y, Oumouna M, Kim H, Ju J, Ronchi VP, Haas AL, Boulares AH. PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model. Allergy. 2011 Jan 28.

2009

Naura AS, Datta R, Hans CP, Zerfaoui M, Rezk BM, Errami Y, Oumouna M, Matrougui K, Boulares AH. Reciprocal regulation of iNOS and PARP-1 during allergen-induced eosinophilia. Eur Respir J. 2009 Feb 1; 33(2): 252-62.

2007

Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S, Fallon K, Woods C, Boulares AH. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death. Circulation. 2007 May 8;115(18):2442-50.

2006

Oumouna M, Datta R, Oumouna-Benachour K, Suzuki Y, Hans C, Matthews K, Fallon K, Boulares H. Poly(ADP-ribose) polymerase-1 inhibition prevents eosinophil recruitment by modulating Th2 cytokines in a murine model of allergic airway inflammation: a potential specific effect on IL-5. J Immunol. 2006 Nov 1;177(9):6489-96.

Patient experience rating

(based on 54 submissions)
  • Provider listened carefully
    4.6 of 5
  • Trust provider with care
    4.5 of 5
  • Provider gave enough info about child's health
    4.5 of 5
  • Would recommend the provider
    4.5 of 5
Learn about the patient experience rating system

About the Patient Experience Rating System

The patient experience rating is an average of all responses to the care provider-related questions from surveys submitted by patient families and verified by our survey partner National Research Corporation (NRC Health), an independent company that specializes in patient experience. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Responses are measured using percent positive scoring. Percent positive is the percentage of respondents who answered with the most desirable response. We are committed to transparency and sharing the voices of our patients and families. Comments are reviewed before posting to ensure accuracy, privacy, and relevance. To provide meaningful feedback, comments are displayed on provider profiles once a sufficient number have been received. All feedback is also shared internally to support learning, recognition, and continuous improvement. The comments reflect the experiences and perspectives of the patients and families who submitted them. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.